Table: OncoTherapy Science -Q1 group results

OncoTherapy Science

10/08/2023 09:00

Aug 10 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            148 mln             385 mln                    
                 (-61.6 pct)        (+313.9 pct)                  
  Operating     loss 386 mln        loss 307 mln                  
  Recurring     loss 397 mln        loss 314 mln                  
  Net           loss 400 mln        loss 277 mln                  
  EPS           loss 1.99 yen       loss 1.44 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T